Comparison of RNA- and DNA-based methods for measurable residual disease analysis in NPM1-mutated acute myeloid leukemia.
Pettersson L, Johansson Alm S, Almstedt A, Chen Y, Orrsjö G, Shah-Barkhordar G, Zhou L, Kotarsky H, Vidovic K, Asp J, Lazarevic V, Saal LH, Fogelstrand L, Ehinger M.
Pettersson L, et al. Among authors: kotarsky h.
Int J Lab Hematol. 2021 Aug;43(4):664-674. doi: 10.1111/ijlh.13608. Epub 2021 May 30.
Int J Lab Hematol. 2021.
PMID: 34053184